Related Experiment Video
Updated: Oct 15, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Patterns of cardiovascular diseases in COVID-19 patients admitted to tertiary cardiac care centre
Beeresha Puttegowda1, Arun B Shivashankarappa1, Suvradip Dutta1
1Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, India.
Insights
The most frequent cardiovascular disease in COVID-19 patients was acute coronary syndrome (ACS), particularly ST-segment elevation myocardial infarction (STEMI). Advanced age and specific biomarkers predict higher mortality risk in these patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- COVID-19 can significantly impact cardiovascular health.
- Understanding cardiovascular disease (CVD) patterns in COVID-19 patients is crucial for management.
- Tertiary cardiac care centers play a vital role in treating complex cardiovascular cases.
Purpose of the Study:
- To analyze the spectrum of cardiovascular diseases (CVDs) in patients with COVID-19.
- To identify risk factors associated with mortality in COVID-19 patients with CVDs.
Main Methods:
- Retrospective analysis of 511 adult COVID-19 patients with new or pre-existing CVDs.
- Inclusion of data on clinical features, ECG, echocardiography, biomarkers, and laboratory parameters.
- Analysis of in-hospital mortality and associated clinical factors.
Main Results:
- Acute coronary syndrome (ACS) was the most common CVD (50.7%), with ST-segment elevation myocardial infarction (STEMI) being more frequent than non-ST-segment elevation ACS (NSTE-ACS).
- Possible myocarditis (10.1%) and rhythm/conduction abnormalities (28.2%) were also observed.
- In-hospital mortality was 18.9%, associated with older age, elevated serum ferritin, D-dimer, NT-pro-BNP, leukocytosis, lymphopenia, lower hemoglobin, pre-existing CVDs, heart failure, cardiogenic shock, atrial fibrillation, and renal failure.
Conclusions:
- Acute coronary syndrome (ACS) is the predominant cardiovascular disease manifestation in COVID-19 patients.
- Several clinical and laboratory markers, including advanced age, elevated inflammatory markers, and pre-existing cardiovascular conditions, are significantly associated with increased mortality.
- Early identification and management of these risk factors are essential for improving outcomes in COVID-19 patients with cardiovascular complications.
Objectives:
To analyse the pattern of cardiovascular diseases (CVDs) in COVID-19 patients admitted to tertiary cardiac care centre.
Methods:
We retrospectively analysed 511 adult patients admitted between July 1, 2020, and November 30, 2020, with COVID-19 infection and having either new onset or pre-existing CVDs. Clinical features, electrocardiogram (ECG), echocardiography, chest X-ray, biomarkers, haematological and biochemical parameters were analysed.
Results:
The mean age of the patients was 56.62 ± 14.74 years. Male: Female ratio was 2.78:1. Pre-existing CVDs were present in 258 patients (50.5%). The most common cardiovascular manifestation was acute coronary syndrome (ACS), seen in 259 patients (50.7%). ST-segment elevation myocardial infarction (STEMI) was more common than non-ST-segment elevation ACS (NSTE-ACS). Possible myocarditis was seen in 52 patients (10.1%). Rhythm and conduction abnormalities were noted in 144 patients (28.2%), the most common being QT prolongation, seen in 51 patients (10%). In-hospital mortality occurred in 97 patients (18.9%). Age, serum Ferritin level, D-dimer, NT-pro-BNP and total leukocyte count were significantly higher among patients with in-hospital mortality compared to survival group. Blood lymphocyte count and Haemoglobin level were significantly lower in mortality-group, compared to survival-group. Incidence of pre-existing CVDs, cardiogenic shock, heart failure, atrial fibrillation (AF), and renal failure were significantly higher in mortality-group compared to survival-group.
Conclusion:
The most common CVD in COVID-19 patients in our study was ACS. STEMI was more common than NSTE-ACS. Advanced age, elevated serum ferritin, D-dimer, NT pro-BNP, leucocytosis, lymphopenia, lower haemoglobin, pre-existing CVDs heart failure, cardiogenic shock, AF and renal failure were associated with increased mortality in these patients.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations